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Abstract
Genetic association studies lead to simultaneous categorical data analysis. The sample
for every genetic locus consists of a contingency table containing the numbers of observed
genotype-phenotype combinations. Under case-control design, the row counts of every ta-
ble are identical and fixed, while column counts are random. The aim of the statistical
analysis is to test independence of the phenotype and the genotype at every locus. We
present an objective Bayesian methodology for these association tests, utilizing the Bayes
factor proposed by Good (1976) and Crook and Good (1980). It relies on the conjugacy of
Dirichlet and multinomial distributions, where the hyperprior for the Dirichlet parameter is
log-Cauchy. Being based on the likelihood principle, the Bayesian tests avoid looping over
all tables with given marginals. Hence, their computational burden does not increase with
the sample size, in contrast to frequentist exact tests. Making use of data generated by
The Wellcome Trust Case Control Consortium (2007), we illustrate that the ordering of the
Bayes factors shows a good agreement with that of frequentist p-values. Furthermore, we
deal with specifying prior probabilities for the validity of the null hypotheses, by taking link-
age disequilibrium structure into account and exploiting the concept of effective numbers
of tests. Application of a Bayesian decision theoretic multiple test procedure to The Well-
come Trust Case Control Consortium (2007) data illustrates the proposed methodology.
Finally, we discuss two methods for reconciling frequentist and Bayesian approaches to
the multiple association test problem for contingency tables in genetic association studies.
1 Introduction
Testing for association between two categorical variates by means of contingency table data is
a classical problem in statistics which can at least be traced back to Pearson (1900) and Fisher
(1922). For a comprehensive account of frequentist tests for this problem we defer the reader
to Agresti (2002). Bayesian methodology for categorical data analysis is nicely summarized by
Agresti and Hitchcock (2005); see also Gómez-Villegas and González-Pérez (2010) for later
developments.
In this work, we are considered with applications of Bayesian inference for contingency tables
to the field of genetic association studies with case-control setup. From the statistical point of
view, such studies lead to the problem of simultaneous categorical data analysis, meaning that
many contingency tables have to be analyzed simultaneously. Assuming a set of m > 1 bi-
allelic genetic markers with exactly two possible values Aj,1 and Aj,2 (say) for 1 ≤ j ≤ m, the
data for genetic locus j can in such type of study be summarized as in Table 1. Typically, single
nucleotide polymorphisms (SNPs) are used as markers, such that Aj,1, Aj,2 ∈ {A,C,G, T}
encode base pairs. However, our methodology is not restricted to SNP studies, but can also be
applied to more complex markers such as copy number variations (CNVs) of sections of the
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deoxyribonucleic acid (DNA), as long as the CNVs have the same binary status as SNPs as
considered by McCarroll et al. (2008), for example.
Table 1: Schematic representation of data for an association test problem at genetic locus j,
where the two possible alleles are denoted by Aj,1 and Aj,2.
Genotype Aj,1Aj,1 Aj,1Aj,2 Aj,2Aj,2
∑
Phenotype 1 x
(j)
11 x
(j)
12 x
(j)
13 n1.
Phenotype 0 x
(j)
21 x
(j)
22 x
(j)
23 n2.
Absolute count n.1
(j) n.2
(j) n.3
(j) N
The numbers n1. of cases (phenotype 1) and n2. of controls (phenotype 0) do not depend on
j and are fixed by experimental design. The aim of the statistical analysis is to test the family
of hypotheses H = (Hj : 1 ≤ j ≤ m), where the j-th null hypothesis Hj states that the
genotype at locus j is stochastically independent of the (binary) phenotype of interest. The
corresponding (two-sided) alternatives are denoted byKj , 1 ≤ j ≤ m.
In the remainder of this work, for notational convenience, we will write x =
(
x11 x12 x13
x21 x22 x23
)
instead of x(j) =
(
x
(j)
11 x
(j)
12 x
(j)
13
x
(j)
21 x
(j)
22 x
(j)
23
)
for the data sample if only one specific locus is con-
cerned. Similarly, we will in such cases drop the subscript j inH andK and the superscript j in
n.1, n.2, and n.3 for ease of presentation, although column counts depend on j. The conditional
probability of observing x under the null hypothesis of no association, given all marginal counts
n = (n1., n2., n.1, n.2, n.3)
>, will be denoted by f(x|n) and is (in a compact, self-explaining
notation) given by
f(x|n) =
∏
n∈n n!
N !
∏
x∈x x!
. (1)
Frequentist exact tests enumerate all tables x˜ with marginals equal to n according to some
real-valued test statistic T : X → R in order to compute a p-value, cf. Langaas and Bakke
(2013) and references therein. Assuming that T tends to smaller values under the alternative,
the non-asymptotic p-value based on T and conditional to n is given by
pT (x) =
∑
x˜:T (x˜)≤T (x)
f(x˜|n) = P (T (X) ≤ T (x)|H,n) . (2)
The remaining part of the paper is structured as follows. In Section 2, we revisit and work up
the computation of Bayes factors for testing association in a single contingency table according
to Good (1976) and Crook and Good (1980). Section 3 is devoted to the numerical computa-
tion of these Bayes factors. In Section 4, we apply the proposed Bayes factors to real genetic
association data generated by The Wellcome Trust Case Control Consortium (2007). Section
5 completes the probability model by discussing prior probabilities for the null hypotheses Hj ,
1 ≤ j ≤ m, and we apply a Bayesian decision theoretic multiple comparison procedure to the
data from Section 4. In Section 6, two methods are provided for reconciling the frequentist and
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the Bayesian approach to the multiple association test problem. These methods may be consid-
ered as alternatives to the asymptotic (N → ∞) approach by Wakefield (2009). We conclude
with a discussion in Section 7.
2 Statistical methodology
Motivated by the conjugacy of Dirichlet and multinomial distributions, Good (1976) and Crook
and Good (1980) proposed objective Bayesian inference for one single contigency table in the
following manner.
Let X = (Xν)1≤ν≤t denote a random vector with t integer elements which takes values in the
discrete set
X = {(x1, . . . , xt)
> ∈ Nt0 : 0 ≤ xν ≤ N for all 1 ≤ ν ≤ t,
t∑
ν=1
xν = N}.
Furthermore, consider a vector p = (p1, . . . , pt)
> which is Dirichlet distributed on the (closed)
unit simplex in [0, 1]t with parameter vector a = (a1, . . . , at)
>, such that the conditional dis-
tribution of X given p is multinomial with t categories, total sample size N and vector p of cell
probabilities, M(t, N,p) for short. Assuming a1 = a2 = . . . = at = a, the unconditional
distribution ofX is the (symmetric) Dirichlet-multinomial distribution with flattening parameter a,
which we will denote by DMultinomial(t, N, a). Its probability mass function is given by
DMultinomial ((xν)|t, N, a) =
(
N
(xν)
)
Γ(ta)
{Γ(a)}t
∏t
ν=1 Γ(xν + a)
Γ(N + ta)
, (xν) ∈ X ; (3)
see, for instance, Section 6.1.2 of Ng et al. (2011). In (3) and throughout the remainder, we use
the abbreviated notation (xν) for (x1, . . . , xt)
>. In the derivations of Good (1976) and Crook
and Good (1980), the function Φ, given by
Φ((xν), t, t
′) =
∫ ∞
0
DMultinomial ((xν)|t, N, a)φ
(a
t′
) da
t′
, (4)
plays a crucial role. In (4) and throughout the remainder, φ denotes the Lebesgue density of the
log-Cauchy distribution with location 0 and scale pi, given by
φ(u) =
1
u[pi2 + ln2(u)]
, u > 0. (5)
As argued by Good (1976), p. 1163, the log-Cauchy(0, pi) hyperprior for the flattening parameter
is a proper proxy for the improper Jeffrey-Haldane density u 7→ u−1, and therefore particularly
suitable for objective Bayesian contingency table analysis. Henceforth, the symmetric Dirichlet
mixture prior with t categories and log-Cauchy(0, pi) hyperprior with scaling parameter t′ for a
is denoted byD∗(t, t′).
Returning to the case-control studies introduced in Section 1, recall that the row sums n1. and
n2. are necessarily the same for all 1 ≤ j ≤ m and fixed by experimental design. Hence, for
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one specific locus and under the corresponding null hypothesis, the only unknown model pa-
rameters are the multinomial probabilities p.1, p.2, and p.3 for the column counts. Good (1976)
proposed the D∗(3, 1) prior for (p.1, p.2, p.3)
> under the null, leading to a prior probability
of Φ((n.k), 3, 1) for the column counts, where 1 ≤ k ≤ 3. Based on this, the probability
of observing x under the null is equal to P(x|n1., n2., H) = Φ((n.k), 3, 1)× f(x|n). Analo-
gously, under the alternative, theD∗(6, 1) prior is assumed for the six unknown cell probabilities
(pik : 1 ≤ i ≤ 2, 1 ≤ k ≤ 3), such that Φ(x, 6, 1) gives the unconditional probability of ob-
serving x under the alternative. As the Dirichlet priorD∗(6, 1) necessarily implies theD∗(2, 3)
prior for the row counts, we obtain that P(x|n1., n2., K) = Φ(x, 6, 1)/Φ((n1., n2.)
>, 2, 3).
Altogether, this entails the Bayes factor
F2 =
P(x|n1., n2., H)
P(x|n1., n2., K)
=
Φ
(
(n1., n2.)
>, 2, 3
)
Φ((n.k), 3, 1)f(x|n)
Φ(x, 6, 1)
for testing H versus K, where the subscript 2 indicates that only the column counts (second
dimension of the table) are random.
Remark 1.
(i) Actually, Good (1976) and Crook and Good (1980) developed the methodology described
in this section for general (R × C)-tables. For our purposes, however, only the special
case of R = 2 and C = 3 is relevant.
(ii) Crook and Good (1980) also discussed further choices for the scale parameter, say s,
of the log-Cauchy density in (5). Exemplary computations (not shown here) however in-
dicated that the Bayes factor F2 is not very sensitive with respect to s, at least if F2 is
small. Therefore, we made use of the original recommendation by Good (1976) and took
s = pi.
3 Computational details
Although the computation of F2 is rather straightforward, some caution is required in actual
implementation. As far as software is concerned, we implemented all routines described in this
section in MATLAB. This choice is mainly motivated by the fact that MATLAB provides the fully
vectorized function gammaln for evaluating the logarithmic Gamma function, which plays a
pivotal role in computing F2. Based on this function, the computation of f(x|n) has already
been described in Section 5 of Dickhaus et al. (2012).
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3.1 Computation of DMultinomial((xν)|t, N, a)
Taking logarithms in (3), we obtain that
ln (DMultinomial ((xν)|t, N, a)) =
[
ln(Γ(N + 1))−
t∑
ν=1
ln(Γ((xν + 1))
]
+ (6)
ln
(
Γ(ta)
{Γ(a)}t
∏t
ν=1 Γ(xν + a)
Γ(N + ta)
)
. (7)
The right-hand side of (6) is directly evaluatable with the gammaln function, while the sum-
mand displayed in (7) is efficiently implemented in the contributed MATLAB program
polya_logProb.m from the Fastfit toolbox by Thomas Minka.
As one additional pitfall, notice that the log-Cauchy distribution can produce extremely large real-
izations of the flattening parameter a, which leads to numerical problems in thepolya_logProb.m
program. On the other hand, we can exploit the well-known fact that the symmetric Dirichlet dis-
tribution degenerates for a→∞, such that the random vector p = (p1, . . . , pt)
> tends to the
constant vector p∗ = (t−1, . . . , t−1)> almost surely as a → ∞. Consequently, it is possible
to accurately approximate DMultinomial(t, N, a) by M(t, N,p∗) whenever a exceeds some
threshold aupper. In our implementation, we chose aupper = 10
6. This choice was motivated
by some preliminary example computations which indicated that, within the range of numerical
double precision, the difference between DMultinomial(t, N, a) andM(t, N,p∗) is negligible
for a > 106.
3.2 Computation of Φ((xν), t, t
′)
Recall that
Φ((xν), t, t
′) =
∫ ∞
0
DMultinomial ((xν)|t, N, a)φ
(a
t′
) da
t′
= EA∼t′ log-Cauchy(0,pi) [DMultinomial ((xν)|t, N,A)] . (8)
While the integral representation in (4) appears more convenient for numerical evaluation, it
turned out that numerical integration with respect to φ is rather challenging. Neither the quadra-
ture routines in MATLAB nor those in R could even verify that φ is a probability density. There-
fore, we made use of the equivalent representation in (8) and performed Monte Carlo inte-
gration. Namely, the theoretical expectation in (8) was replaced by the arithmetic mean of the
integrand evaluated at B pseudo-random numbers which behave like independent realizations
of A ∼ t′log-Cauchy(0, pi). In our implementation, we used B = 100,000, leading to a small
Monte Carlo standard error.
3.3 Computational complexity
As mentioned in the discussion around (1) and (2), a loop over all possible tables with given
marginals n cannot be avoided if exact frequentist tests are to be carried out. Clearly, the num-
ber of such tables that have to be enumerated increases drastically with the sample size N ,
5
see Bakke and Langaas (2012). Unconditional asymptotic tests, typically based on chi-square
approximations, are often considered a convenient alternative for large N . However, the chi-
square approximation can be very poor in extreme tail areas, even ifN is very large, cf. Langaas
and Bakke (2013). Hence, ifm is large and a strong multiplicity adjustment is necessary (high
quantiles of the null distribution of the test statistic are needed), the chi-square approximation
is doubtful. Clearly, there are other (asymptotic or non-asymptotic) frequentist test approaches
which are under certain assumptions on the expected cell counts more robust than chi-square
tests; see, e. g., Lydersen et al. (2009) for a biostatistics tutorial with practical guidelines for
choosing a marginal testing strategy in the case of a (2 × 2)-table. However, an automated
application of such guidelines for a large number of contingency tables simultaneously, where
parameters like the expected minor allele frequency are prone to change considerably from one
genomic position to the other, appears extremely challenging.
In contrast to these problems, the computational complexity of computing F2 remains constant
for any N . Plainly speaking, the reason is that the parameter space for (pik : 1 ≤ i ≤ 2, 1 ≤
k ≤ 3) is independent of N , while the sample space X crucially depends on N . Being based
on the likelihood principle, Bayesian tests do not have to explore the sample space, but the
parameter space. Also, no asymptotic considerations are required. The only costly (non-scalar)
operation in our implementation of F2 is the generation of B pseudo-random Cauchy numbers,
see Section 3.2. However, from our experience it is not necessary to choose B as a function of
N .
Remark 2. All MATLAB worksheets that were used to derive the results presented in this paper
are available as supplementary material from the author upon request.
4 Computation of Bayes factors from real data
In this section, we apply the proposed methodology to the Crohn’s disease substudy reported
by The Wellcome Trust Case Control Consortium (2007). More precisely, we restricted our
attention tom = 1,778 pre-screened loci. The pre-screening has been performed by sample-
splitting with respect to N and applying a false discovery rate-based screening criterion to
the first subsample of size N/2 as described in Section 6.2 of Dickhaus et al. (2012). The
computation of F
(j)
2 for 1 ≤ j ≤ m = 1,778 was performed on the second subsample which
has not been used for screening. This mimics a two-stage study design which is often chosen
in genome-wide association studies.
Table 2 displays the 34 smallest of the 1,778 Bayes factors in increasing order. Bold-face rows
indicate SNPs that were declared significantly associated with Crohn’s disease by the multiple
test from Section 3.4 of Dickhaus et al. (2012); see Table 3 in their paper. It becomes apparent
that the 34 positions with smallest Bayes factors comprise 23 out of the 24 loci with significant
associations reported by Dickhaus et al. (2012). A closer investigation of the data corresponding
to the only “non-replicated“ SNP, namely rs11816049 with Bayes factor F
(rs11816049)
2 = 6.85722,
revealed that the significance reported in Table 3 of Dickhaus et al. (2012) for this SNP is actually
an artifact of their randomization technique. The contingency table for this locus is given by
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x(rs11816049) =
(
0 1 874
0 0 1468
)
. Conditional to all five marginal counts, there are only two
possible realizations of this table. Therefore, one can randomize the entire table probability of
f(x(rs11816049)|n) = 0.3735, and this has lead to the artifactually small p-value for rs11816049
in Table 3 of Dickhaus et al. (2012). The last column of Table 2 compares the frequentist p-
values with Bayes factors quantitatively. Namely, we applied the “p-value calibration“ method
B(p) by Sellke et al. (2001) to the p-values from the fourth column. As the authors argue below
their equation (2),B(p) provides a lower bound on the Bayes factor. This property is numerically
verified by our data.
While Table 2 focusses on the 34 smallest Bayes factors, Figure 1 displays a scatter plot of
p-values against Bayes factors for all m = 1,778 SNPs under investigation. The high value
of approximately 0.69 for Spearman’s rank correlation coefficient between the two quantities
confirms that the good accordance between the orderings of frequentist p-values and Bayes
factors extends beyond the subset of small Bayes factors.
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0
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Spearman rho = 0.6884
Figure 1: Scatter plot of p-values against Bayes factors computed from data for m = 1,778
pre-screened genomic positions. Data were generated by The Wellcome Trust Case Control
Consortium (2007), sub-study for Crohn’s disease.
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Table 2: The 34 smallest Bayes factors computed from the data on Crohn’s disease reported by
The Wellcome Trust Case Control Consortium (2007). Bold-face rows correspond to significant
associations when applying the frequentist multiple test from Section 3.4 of Dickhaus et al.
(2012). The last column contains a lower bound on the Bayes factor as a function of the p-value
from the fourth column; see equation (2) of Sellke et al. (2001).
Chromosome SNP Bayes factor F2 p-value B(p)
2 rs6752107 8.202e-07 1.243e-08 6.151e-07
2 rs10210302 9.218e-07 1.374e-08 6.762e-07
2 rs6431654 9.521e-07 1.461e-08 7.165e-07
2 rs3792106 9.738e-07 1.264e-08 6.248e-07
2 rs3828309 2.400e-06 3.709e-08 1.725e-06
1 rs11805303 0.0001377 1.528e-06 0.00005563
5 rs17234657 0.0003479 9.397e-07 0.00003545
16 rs2076756 0.0006028 3.835e-06 0.0001300
5 rs9292777 0.0006926 7.460e-06 0.0002394
5 rs1505992 0.0008678 5.337e-06 0.0001761
1 rs2201841 0.0009063 8.980e-06 0.0002837
5 rs11750156 0.001321 6.876e-06 0.0002222
5 rs1122433 0.001467 7.619e-06 0.0002441
5 rs10055860 0.001531 8.035e-06 0.0002562
5 rs1553577 0.002525 1.590e-05 0.0004775
1 rs10489629 0.002814 4.325e-05 0.001181
5 rs1553576 0.003703 2.262e-05 0.0006578
5 rs4957317 0.004201 2.635e-05 0.0007552
5 rs4957313 0.004259 2.681e-05 0.0007671
5 rs6896604 0.005239 3.293e-05 0.0009238
1 rs12119179 0.005239 5.510e-05 0.001469
5 rs6866402 0.007412 4.746e-05 0.001284
16 rs17221417 0.008712 7.688e-05 0.001980
16 rs2066843 0.008857 6.230e-05 0.001640
5 rs10473203 0.009061 4.716e-05 0.001277
5 rs11747270 0.009616 1.610e-05 0.0004831
1 rs11209033 0.009909 0.0001071 0.002661
7 rs10228407 0.01140 0.0002086 0.004806
5 rs4957295 0.01679 0.0001104 0.002736
5 rs10213846 0.01827 0.0001164 0.002867
16 rs3135499 0.01897 0.0002507 0.005650
5 rs11957134 0.01954 3.629e-05 0.001009
5 rs4957297 0.02126 0.0001369 0.003310
5 rs1000113 0.02264 4.210e-05 0.001153
5 Decision theoretic multiple comparisons
5.1 Prior probabilities for the null hypotheses
For the application of Bayesian decision theoretic multiple comparison procedures as consid-
ered, for instance, by Müller et al. (2004), Müller et al. (2007) and León-Novelo et al. (2013),
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the probability model from Section 2 has to be completed by specifying prior probabilities for the
null hypotheses Hj , 1 ≤ j ≤ m. In this, especially for largem, it is common practice to assign
the same prior probability pi0 (say) to each Hj ; cf., for instance, Chapter 2 of Efron (2010) and
the references therein. Principled ways towards a multiplicity-adjusted choice of pi0 have been
presented by Dawid (1987) and Scott and Berger (2010), among others. Assuming exchange-
ability of the Hj , Dawid (1987)’s proposal was to take pi0 = Π
1/m
0 , where Π0 = Prob(H0),
H0 =
⋂m
j=1Hj , is specified by the researcher. Westfall et al. (1997) extended Dawid (1987)’s
idea to cases with strong dependencies between the null hypotheses. In the context of genetic
association studies, such strong dependencies are present at least in blocks of loci which are
in linkage disequilibrium (LD) with each other. LD is the technical way to refer to correlations
between the allelic states of different genetic markers in the same chromosome, see Lewontin
and Kojima (1960). In human populations some combinations of alleles along the same chro-
mosome (haplotypes) occur at frequencies that are different from what would be expected out
of random combinations of the markers’ allelic frequencies. The biological reason for this is the
mechanism of inheritance, which implies that blocks of DNA are necessarily inherited jointly. It
is important to note that LD information is available from external databases (for example, those
by The International HapMap Consortium (2005) and The 1000 Genomes Consortium (2010))
before the actual study data are ascertained. Therefore, utilization of LD in the definition of pi0
is recommendable. Based on this idea, we propose to modify pi0 = Π
1/m
0 in thatm is replaced
by the effective number of testsMeff.; cf. Dickhaus and Stange (2013), Section 4.3 of Dickhaus
(2014), and references therein. In particular, quantification of Meff. on the basis of probability
bounds of order 2 (making use of the bivariate between-marker correlations, i. e., the LD coeffi-
cients) has been advocated by Moskvina and Schmidt (2008) and Dickhaus and Stange (2013).
For the example described in Section 4, Dickhaus et al. (2012) applied this method and arrived
at an effective number of tests ofMeff. = 1,350.45 < m = 1,778.
Remark 3. The methodology by Moskvina and Schmidt (2008) and Dickhaus and Stange (2013)
for computing Meff. makes use of probability bounds for chi-square test statistics. These are
not part of our Bayesian probability model. A generic method for computing the effective num-
ber of tests, which only depends on the eigenvalues of the LD matrix, has been developed by
Cheverud (2001) and Nyholt (2004). In practice, however, their method leads to very large ef-
fective numbers of tests and its usage is therefore not recommended (Dickhaus et al. (2012)).
Another method which is solely based on a principal component analysis of the LD matrix is the
simpleM method derived by Gao et al. (2008).
5.2 Application of Bayesian multiple tests to real data
Here, we return to the real data example from Section 4 and explain how to apply one spe-
cific Bayesian decision theoretic multiple comparison procedure to this dataset. First, making
use of the methodology described in Section 5.1, we transformed Bayes factors into posterior
probabilities, by computing
1− vj = P(Hj |data) =
F
(j)
2
pi1/pi0 + F
(j)
2
, pi1 = 1− pi0, 1 ≤ j ≤ m.
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Next, we consider actions (decisions) dj ∈ {0, 1}, where dj = 1 has the interpretation thatHj
gets rejected (decision in favor of Kj), 1 ≤ j ≤ m. Following Müller et al. (2004), we let the
posterior expected counts of false positive and false negative decisions, respectively, be defined
as
FD =
m∑
j=1
dj(1− vj), FN =
m∑
j=1
(1− dj)vj ,
and consider the expected posterior loss (i. e., posterior risk) functional given by
R(d, data) = cFD+ FN, d = (d1, . . . , dm)
>,
for a given cost parameter c > 0. The functional R(d, data) is a natural extension of (0, 1, c)
loss functions for testing a single hypothesis to the multiple testing setting (cf. Müller et al.
(2004), p. 992).
Proposition 1 (Theorem 1 of Müller et al. (2004)). The Bayes-optimal decisions under the risk
functional R(d, data) are given by
dj = 1⇐⇒ vj ≥ c/(c+ 1), 1 ≤ j ≤ m.
Proposition 1 shows that the decision in favor ofKj takes place as soon as the posterior prob-
ability vj for the validity ofKj is large enough (depending on the cost c). Since vj is an antitone
transformation of F
(j)
2 , dj equivalently amounts to a thresholding of these Bayes factors.
Table 3 lists the number of rejections (according to the decision rule defined in Proposition 1) as
a function of Π0 and c. As expected, the number of rejections is a decreasing function both of
c and of Π0. If c = 0, then only the type II error component contributes to the risk R(d, data),
such that R(d, data) can trivially be optimized by rejecting all null hypotheses. However, as c
increases, the number of rejections sharply decreases. This is the price that has to be paid for
the high (effective) multiplicity of the problem, because pi0 = Π
1/1350.45
0 is close to one for all
considered values of Π0. However, for the SNPs with the five smallest Bayes factors (namely
those which are smaller that 10−5, see Table 2), the data overrule even large values ofΠ0 and c,
such that the corresponding five null hypotheses are rejected under any parameter configuration
in Table 3.
6 Frequentist-Bayes reconciliation
The good accordance between frequentist p-values and Bayes factors that we have reported
in Section 4 leads to the question if the frequentist and the Bayesian approach can be recon-
ciled under our setup. To this end, Wakefield (2009) considered the saturated logistic regression
model corresponding to the contigency table data for testing genetic associations. In an asymp-
totic setting (N → ∞), he derived a Gaussian prior for the regression coefficients which is
guaranteed to lead to an ordering of the Bayes factors which coincides with that of frequentist
p-values.
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Table 3: Number of rejected null hypotheses according to the decision rule from Proposition 1
as a function of the prior probability Π0 for the global hypothesis H0 and the cost parameter c.
Π0 c number of rejections Π0 c number of rejections
0.1 0.0000 1778 0.7 0.0000 1778
0.1 0.0125 51 0.7 0.0125 32
0.1 0.0250 45 0.7 0.0250 27
0.1 0.0500 38 0.7 0.0500 21
0.1 0.1000 29 0.7 0.1000 15
0.1 0.2500 21 0.7 0.2500 11
0.1 0.5000 16 0.7 0.5000 7
0.1 1.0000 14 0.7 1.0000 6
0.1 2.0000 9 0.7 2.0000 5
0.1 4.0000 7 0.7 4.0000 5
0.1 10.0000 6 0.7 10.0000 5
0.3 0.0000 1778 0.9 0.0000 1778
0.3 0.0125 45 0.9 0.0125 21
0.3 0.0250 39 0.9 0.0250 16
0.3 0.0500 29 0.9 0.0500 14
0.3 0.1000 24 0.9 0.1000 9
0.3 0.2500 16 0.9 0.2500 6
0.3 0.5000 14 0.9 0.5000 6
0.3 1.0000 10 0.9 1.0000 5
0.3 2.0000 7 0.9 2.0000 5
0.3 4.0000 6 0.9 4.0000 5
0.3 10.0000 5 0.9 10.0000 5
0.5 0.0000 1778
0.5 0.0125 40
0.5 0.0250 32
0.5 0.0500 27
0.5 0.1000 19
0.5 0.2500 14
0.5 0.5000 11
0.5 1.0000 7
0.5 2.0000 6
0.5 4.0000 5
0.5 10.0000 5
As outlined in Section 4, one computationally very inexpensive method to transform F2 to the p-
value scale is to apply the inverse transformation [B(p)]−1 (Sellke et al. (2001)) to F2, provided
that F2 is smaller than 1. This leads to the upper p-value bound
p(F2) = −
F2
e× LambertW(−1,−F2/e)
, (9)
where e = exp(1) and LambertW(−1, ·) denotes the branch of the Lambert W function with
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parameter k = −1, see http://www.maplesoft.com/support/help/Maple/
view.aspx?path=LambertW for details. The right-hand side of (9) is easily computable
with standard statistics software. Since B(p) is a one-to-one mapping for p ∈ (0, e−1), it is
guaranteed that the order of the Bayes factors and that of the upper p-value bounds defined by
(9) coincide. However, in terms of statistical significance, this approach is conservative, because
p(F2) is an upper bound on the actual p-value and may not be sharp.
Based on our considerations from Sections 1 and 2, a maybe more straightforward, albeit com-
putationally very intensive approach towards the reconciliation problem consists in interpreting
the Bayes factor as a statistic F2 : X → R and carrying out a frequentist significance test
based on this test statistic. Let us briefly outline a simulation scheme for a Monte Carlo approx-
imation of the distribution of F2 under H (Algorithm 1). For this, we denote by f
∗
2 the actually
observed value of the Bayes factor F2 at a given genetic locus based on the corresponding
contingency table x.
Algorithm 1.
0. Take n1., n2., and f
∗
2 as input. Fix a number BMC of Monte Carlo repetitions. Initialize the
integer counter with 1.
1. For b from 1 to BMC do:
(a) Draw a pseudo-random number a(b) from the log-Cauchy(0, pi) distribution.
(b) Draw a pseudo-random tuple (n
(b)
.1 , n
(b)
.2 , n
(b)
.3 )
> from DMultinomial(3, N, a(b)). This step
can for instance be performed by making use of the MATLAB routine
polya_sample.m from the Fastfit toolbox by Thomas Minka.
(c) Draw a pseudo-random table x˜(b) from the conditional distribution with point mass func-
tion f(·|n(b)), where n(b) = (n1., n2., n
(b)
.1 , n
(b)
.2 , n
(b)
.3 )
>. This step can be performed
efficiently by making use of the AS 159 algorithm by Patefield (1981). A MATLAB
implementation can be found under the URL http://people.sc.fsu.edu/
~jburkardt/m_src/asa159/asa159.html.
(d) Compute the Bayes factor F
(b)
2 based on x˜
(b). If F
(b)
2 ≤ f
∗
2 , increase counter by 1.
2. Return the relative frequency
pˆF2(x) =
counter
BMC + 1
. (10)
The following result is an immediate consequence of the law of large numbers and the construc-
tion of pˆF2(x).
Proposition 2.
(a) The quantity pˆF2(x) defined in (10) consistently (BMC →∞) approximates the frequen-
tist p-value pF2(x) = P (F2 ≤ f
∗
2 |H).
(b) The p-value pF2(x) is an increasing transformation of f
∗
2 .
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Remark 4. Notice that pˆF2(x) cannot be smaller than (BMC + 1)
−1. In practice, one will there-
fore typically have to choose BMC very large to ensure that pˆF2(x) can possibly be smaller
than a multiplicity-adjusted significance threshold. Since the present paper proposes the usage
of Bayesian decision theoretic multiple comparison procedures, we do not present numerical
values for the pˆF2(x
(j)), 1 ≤ j ≤ m, here.
7 Concluding remarks
We have presented an application in which Bayesian inference is easier and less computational
demanding than (exact) frequentist inference. The main reason for this is that the parameter
space stays constant with increasing sample size, while the cardinality of the sample space
increases withN . Our approach enables the researcher to carry out decision theoretic multiple
comparison procedures for testing genetic associations. Such procedures incorporate the prior
probability for the validity of the global hypothesis as well as potentially non-symmetric costs for
false decisions into the statistical methodology. Furthermore, we discussed several ways how
to transform the proposed Bayes factors (which are very easy to compute in our setting) into
p-values, such that the ordering of both summary statistics with respect to the genetic loci under
investigation is the same.
There are several possible extensions of this work. First, recall that we considered a non-
informative prior for the random column counts (n.1, n.2, n.3)
>. However, in practice there will
often be prior information about the prevalence of the disease (the expected relative frequency
of phenotype 1) and about the locus-specific allele frequencies in the target population. Incor-
porating this information into a different prior for (n.1, n.2, n.3)
> is straightforward. Second, one
may incorporate linkage disequilibrium information not only in the construction ofMeff., but more
explicitly in a probability model for pi0 (cf. Geisser (1984)) or for the observables themselves, as
proposed by Malovini et al. (2012). Third, it may be interesting to study the effect of the discrete-
ness of X on the performance of decision theoretic multiple comparison procedures relying on
posterior probabilities. In the frequentist context, Finner et al. (2010), Habiger and Peña (2011)
and Dickhaus et al. (2012) have recently demonstrated that randomization techniques can in-
crease the statistical power to detect true alternatives in discrete models. Finally, an interesting
and challenging problem consists in adapting the concept of effective numbers of tests to the
Bayesian context. There are at least two possible ways in this respect: One may analyze the
equation piMeff.0 = Π0 under a probability model (with block dependencies) that explicitly incor-
porates the biological mechanism leading to LD, or one may replace the chi-square statistics
considered by Moskvina and Schmidt (2008) and Dickhaus and Stange (2013) by Bayesian
quantities, for instance by local false discovery rates as proposed by Yekutieli (2013).
Finally, one limitation of our approach in comparison to that of Wakefield (2009) is that non-
genetic covariates are not included in our probability model. Future research shall aim at ex-
tending the model such that adjustments for such covariates become possible.
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